Floatz logo

Pentoxiphylline

Hypoalbuminemia

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Hypoalbuminemia cohort.

Asset / SponsorPhaseRating
NORMAL HUMAN SERUM ALBUMIN
Healthgen Biotechnology Corp.
Phase 3BB
Osrhsa
Healthgen Biotechnology Corp.
Phase 3BB
Alpha Tocopherol
University of Ioannina
N/AD
L-AMINO ACIDS
University of Ioannina
N/AD

Same molecule, other indications

Pentoxiphylline is also rated in:

metabolic dysfunction-associated steatohepatitisDormant
B
Indicative ·
60 / 100
View asset →
inflammatory diseaseDormant
B
Indicative ·
60 / 100
View asset →
protein-energy malnutritionDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →